Kymera Therapeutics Inc (KYMR) — Long-term Investment Intensity
Kymera Therapeutics Inc (KYMR) has a Long-term Investment Intensity of 53.6% as of March 2026. Long-term investments of $894.72 Million represent 53.6% of total assets of $1.67 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Kymera Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kymera Therapeutics Inc Long-term Investment Intensity (2020–2025)
This chart shows how Kymera Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the intensity stands at 53.6%, reflecting long-term investments of $894.72 Million against total assets of $1.67 Billion USD. Explore KYMR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Kymera Therapeutics Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for Kymera Therapeutics Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Kymera Therapeutics Inc (KYMR) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 44.2% | $771.16 Million | $1.74 Billion | ▲ +7.2 pp |
| 2024 | 37.0% | $362.16 Million | $978.03 Million | ▲ +26.4 pp |
| 2023 | 10.7% | $61.43 Million | $575.76 Million | ▼ -14.6 pp |
| 2022 | 25.3% | $152.33 Million | $603.13 Million | ▲ +4.6 pp |
| 2021 | 20.7% | $125.19 Million | $605.90 Million | ▼ -12.7 pp |
| 2020 | 33.4% | $162.53 Million | $487.18 Million | — |